Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules - a podcast by Timmerman Report
from 2022-01-31T17:45:19
::
::
Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.
Further episodes of The Long Run with Luke Timmerman
Further podcasts by Timmerman Report
Website of Timmerman Report